Another relevant meta-analysis indicated that tocilizumab could decrease the risk of MACE in RA patients compared to TNF inhibitors, although this finding was marginally non-significant [ 176 ].
← all excerpts
A Comprehensive Review: Unraveling the Role of Inflammation in the Etiology of Heart Failure.
1
—
—